HUMACYTE INC

Insider buying spikes for HUMACYTE show strong confidence despite a 57% YTD drop—discover why directors are piling on shares and what it means for investors.

Insider buying at Humacyte signals confidence amid volatility—Jones purchases 30k shares at $0.59, hinting at a short‑term rally but cautioning on future dilution.

Insider buy‑in of 80,000 zero‑cost options amid HUMACYTE’s public offering signals management confidence and a coordinated effort to align incentives with shareholders, but investors should monitor valuation and market sentiment before buying.